Skip to main content

Table 1 Baseline characteristics of hemodialysis patients according to cognitive function

From: Associations of metabolic syndrome, its severity with cognitive impairment among hemodialysis patients

Characteristics

All (n = 5492)

Normal cognition (n = 3609)

MCI (n = 1883)

P

MMSE score

26.9 ± 3.8

29.2 ± 1.1

22.7 ± 2.6

 < 0.001

Age (year)

54.4 ± 15.2

52.4 ± 15.0

58.2 ± 14.9

 < 0.001

Female sex (n, %)

2141(39.0%)

1309(26.3%)

832(44.2%)

 < 0.001

Smoking history (n, %)

1533 (27.9%)

1021 (28.3%)

512 (27.2%)

0.392

Alcohol history (n, %)

485 (8.8%)

291 (8.1%)

194 (10.3%)

0.006

High educational level (n, %)

2205 (40.1%)

1527 (42.3%)

678 (36.0%)

 < 0.001

Living alone (n, %)

4152 (75.6%)

2876 (79.7%)

1276 (67.8%)

 < 0.001

Diabetes mellitus (n, %)

1512 (27.5%)

906 (25.1%)

606 (32.3%)

 < 0.001

Hypertension (n, %)

4336 (79.0%)

2777 (76.9%)

1559 (82.8%)

 < 0.001

Dialysis vintage (months)

37.0 (15.0, 70.0)

37.0 (15.0, 72.0)

37.0 (15.0, 67.0)

0.356

Dialysis modality (n, %)

   

0.334

HD

490 (8.9%)

312 (8.6%)

178 (9.5%)

 

HD + HDF

678 (12.3%)

462 (12.8%)

216 (11.5%)

 

HD + HP

391 (7.1%)

249 (6.9%)

142 (7.5%)

 

HD + HDF + HP

3933 (71.6%)

2586 (71.7%)

1347 (71.5%)

 

Dialysis access, Fistula (n, %)

4733 (86.2%)

3139 (87.0%)

1594 (84.7%)

0.108

SBP (mmHg)

138.1 ± 20.6

138.1 ± 20.2

138.2 ± 21.2

0.844

DBP (mmHg)

78.6 ± 13.6

97.6 ± 13.6

76.7 ± 13.5

 < 0.001

Body height (cm)

161.0 ± 8.2

161.8 ± 8.1

159.5 ± 8.3

 < 0.001

Body weight (kg)

47.4 ± 19.8

49.9 ± 19.2

42.8 ± 20.0

 < 0.001

Waist circumference (cm)

83.3 ± 10.8

82.8 ± 10.7

84.3 ± 10.8

 < 0.001

Hip circumference (cm)

89.5 ± 8.1

89.3 ± 8.1

89.8 ± 8.1

0.025

Fasting glucose (mmol/L)

7.5 ± 3.8

7.4 ± 3.7

7.7 ± 4.0

0.012

Hemoglobin (g/L)

108.4 ± 20.6

109.0 ± 20.4

107.5 ± 21.0

0.011

TG (mmol/L)

1.51 (1.06, 2.31)

1.49 (1.05, 2.29)

1.55 (1.07, 2.36)

0.060

Cholesterol (mmol/L)

3.90 ± 0.96

3.88 ± 0.97

3.93 ± 0.96

0.059

HDL-c (mmol/L)

1.11 (0.91, 1.35)

1.11 (0.91, 1.35)

1.09 (0.90, 1.35)

0.556

LDL-c (mmol/L)

2.08 (1.63, 2.60)

2.07 (1.63, 2.59)

2.10 (1.63, 2.63)

0.236

MetS (2020 Edition) (%)

3161 (57.6%)

1996 (55.3%)

1165 (61.9%)

 < 0.001

MetS component

2.8 ± 1.1

2.7 ± 1.1

2.9 ± 1.1

 < 0.001

Abdominal obesity (n, %)

1818 (33.1%)

1112 (30.8%)

706 (37.5%)

 < 0.001

Hypertriglyceridemia (n, %)

2384 (43.4%)

1533 (42.5%)

851 (45.2%)

0.055

Low HDL-c (n, %)

2346 (42.7%)

1524 (42.2%)

822 (43.7%)

0.315

Hyperglycemia (n, %)

3550 (64.6%)

2259 (62.6%)

1291 (68.6%)

 < 0.001

High blood pressure (n, %)

5117 (94.3%)

3388 (93.9%)

1789 (95.0%)

0.087

siMS score

3.52 ± 1.28

3.47 ± 1.24

2.62 ± 1.37

 < 0.001

CMI

0.70 (0.44, 1.21)

0.68 (0.43, 1.18)

0.75 (0.44, 1.26)

0.004

MetSSS

0.83 (0.08, 1.70)

0.75 (0.05, 1.62)

0.98 (0.19, 1.88)

 < 0.001

  1. P < 0.05 was considered statistically significant. Values were expressed as mean ± SD, median (25th–75th percentile), or frequency (percentage) as appropriate. MCI Mild cognitive impairment, MMSE Mini-mental state examination, HD Hemodialysis, HDF Hemofiltration; HP Hemoperfusion, SBP Systolic blood pressure, DBP Diastolic blood pressure, TG Triglyceride, HDL High density lipoprotein, LDL Low density lipoprotein, MetS Metabolic syndrome, siMS Metabolic syndrome score, CMI Cardiometabolic index, MetSSS Metabolic syndrome severity score